RxDoctor Payments Data

Sumant Krishnan, MD

Orthopaedic Surgery · Dallas, TXNPI 1013939487

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,766,395 of the $1,901,110 with a category attached, or 92.9%. Stryker accounts for 67.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $461,034 and has fallen 75.5% since, to $113,003 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,901,110in general payments, 2019–2025

Across 119 payments — averaging $15,976 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1.3M
  • DJO, LLC$484K
  • Restor3d, Inc.$129K
  • Limacorporate S.p.a.$275
  • Smith+Nephew$125
  • Shoulder Innovations, Inc.$60

What the payments were for

  • Royalty or licence$1,766,39593%
  • Consulting fees$120,0026%
  • Travel & lodging$8,9200%
  • Food & beverage$5,7930%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)38$1,287,953
DJO, LLC25$483,610
Restor3d, Inc.51$129,088
Limacorporate S.p.a.3$275
Smith+Nephew1$125
Shoulder Innovations, Inc.1$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,901,110 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$378,371
Medicare patients
435
Services billed
3,430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Minocycline Hcl34$1,093
Calcitonin-SalmonCalcitonin,salmon,synthetic21$1,056
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen120$990
Etodolac23$593
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$568
Clindamycin Hcl25$442
Mupirocin42$282
Methylprednisolone39$246
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$210
Methocarbamol26$127
Cephalexin41$73

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →